Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia
Co-Diagnostics (Nasdaq: CODX) will host a virtual fireside chat on November 5, 2025 at 11:00 am ET with CEO Dwight Egan to discuss the company’s growth initiatives and its recently announced definitive agreement with Arabian Eagle to form CoMira Diagnostics in Saudi Arabia.
The discussion will cover plans to advance regional deployment of the Co-Dx PCR platform across the Middle East. A live Q&A will follow; a recording will be posted on Co-Dx investor relations. Attendees may submit questions in advance to CODX@kcsa.com. Registration is available via the provided link. The Co-Dx PCR platform remains subject to regulatory review and is not currently available for sale.
Co-Diagnostics (Nasdaq: CODX) terrà un chat informale virtuale il 5 novembre 2025 alle 11:00 ET con l'amministratore delegato Dwight Egan per discutere le iniziative di crescita dell'azienda e il suo recente accordo definitivo con Arabian Eagle per formare CoMira Diagnostics in Arabia Saudita.
La discussione coprirà i piani per avanzare l'implementazione regionale della Co-Dx PCR platform nel Medio Oriente. Seguirà una sessione di domande e risposte dal vivo; una registrazione sarà pubblicata presso le relazioni con gli investitori di Co-Dx. I partecipanti possono inviare domande in anticipo a CODX@kcsa.com. L'iscrizione è disponibile tramite il link fornito. La piattaforma Co-Dx PCR resta soggetta a revisione regolamentare e al momento non è disponibile per la vendita.
Co-Diagnostics (Nasdaq: CODX) organizará una charla informal virtual el 5 de noviembre de 2025 a las 11:00 a.m. ET con el CEO Dwight Egan para discutir las iniciativas de crecimiento de la empresa y su reciente acuerdo definitivo con Arabian Eagle para formar CoMira Diagnostics en Arabia Saudita.
La discusión cubrirá los planes para avanzar la implementación regional de la Co-Dx PCR platform en Oriente Medio. Le seguirá una sesión de preguntas y respuestas en vivo; se publicará una grabación en las relaciones con inversores de Co-Dx. Los asistentes pueden enviar preguntas por adelantado a CODX@kcsa.com. El registro está disponible a través del enlace proporcionado. La plataforma Co-Dx PCR sigue sujeta a revisión regulatoria y actualmente no está disponible para la venta.
Co-Diagnostics (나스닥: CODX)은 CEO Dwight Egan과 함께 2025년 11월 5일 동부 표준시 오전 11:00에 가상 fireside 채팅을 주최하여 회사의 성장 이니셔티브 및 최근 Arabian Eagle과의 확정 계약으로 CoMira Diagnostics를 사우디아라비아에 설립하는 것에 대해 논의합니다.
논의는 중동 전역에 걸친 Co-Dx PCR 플랫폼의 지역 배치를 추진하기 위한 계획을 다룰 것입니다. 라이브 Q&A가 이어지고, Co-Dx 투자자 관계 페이지에 녹화가 게시될 예정입니다. 참가자는 사전에 CODX@kcsa.com으로 질문을 제출할 수 있습니다. 등록은 제공된 링크를 통해 가능하며, Co-Dx PCR 플랫폼은 규제 심사 대상이며 현재 판매 중이 아닙니다.
Co-Diagnostics (Nasdaq: CODX) organisera une discussion informelle virtuelle le 5 novembre 2025 à 11 h 00 ET avec le PDG Dwight Egan pour discuter des initiatives de croissance de l'entreprise et de son accord définitif récemment annoncé avec Arabian Eagle pour former CoMira Diagnostics en Arabie Saoudite.
La discussion couvrira les plans visant à faire progresser le déploiement régional de la Co-Dx PCR platform au Moyen-Orient. Une séance de questions-réponses en direct suivra; un enregistrement sera publié sur les relations investisseurs de Co-Dx. Les participants peuvent soumettre des questions à l'avance à l'adresse CODX@kcsa.com. L'inscription est disponible via le lien fourni. La plateforme Co-Dx PCR reste soumise à l'examen réglementaire et n'est pas encore disponible à la vente.
Co-Diagnostics (Nasdaq: CODX) wird am 5. November 2025 um 11:00 Uhr ET eine virtuelle Kamin-Chat-Sitzung mit CEO Dwight Egan abhalten, um die Wachstumsinitiativen des Unternehmens und seine kürzlich bekanntgegebene endgültige Vereinbarung mit Arabian Eagle zur Gründung von CoMira Diagnostics in Saudi-Arabien zu besprechen.
Die Diskussion wird Pläne zur Weiterentwicklung der regionalen Bereitstellung der Co-Dx PCR platform im Nahen Osten behandeln. Im Anschluss folgt eine Live-Q&A-Sitzung; eine Aufnahme wird in den Investor-Relations von Co-Dx veröffentlicht. Teilnehmer können im Voraus Fragen an CODX@kcsa.com senden. Die Registrierung ist über den bereitgestellten Link möglich. Die Co-Dx PCR-Plattform unterliegt weiterhin einer behördlichen Prüfung und ist derzeit nicht zum Verkauf erhältlich.
Co-Diagnostics (ناسداك: CODX) ستستضيف محادثة افتراضية بجلسة نار حول 5 نوفمبر 2025 الساعة 11:00 صباحاً بتوقيت شرق الولايات المتحدة مع المدير التنفيذي Dwight Egan لمناقشة مبادرات النمو لدى الشركة واتفاقها النهائي الذي أُعلن مؤخراً مع Arabian Eagle لتشكيل CoMira Diagnostics في المملكة العربية السعودية.
ستناقش المناقشة خطط تعزيز نشر منصة Co-Dx PCR على نطاق الشرق الأوسط. ستعقبها جلسة أسئلة وأجوبة مباشرة؛ سيتم نشر تسجيل في علاقات المستثمرين بـ Co-Dx. يمكن للمشاركين تقديم أسئلة مقدماً إلى CODX@kcsa.com. التسجيل متاح عبر الرابط المقدم. تظل منصة Co-Dx PCR خاضعة للمراجعة التنظيمية وليست متاحة للبيع حالياً.
- None.
- None.
Join Dwight Egan, CEO of Co-Dx, for an update on the Company's growth initiatives, including its recently announced definitive agreement with Arabian Eagle in the
Virtual Fireside Chat Details
|
Date: |
November 5, 2025 |
|
Time: |
11:00 am ET |
|
Registration Link: |
A Q&A session will take place at the end of the discussion, and a recording of the fireside chat will be available on Co-Dx's Investor Relations website following the event. To ensure your questions are addressed, please submit them in advance to CODX@kcsa.com.
*The Co-Dx PCR platform (including the PCR Home™, PCR Pro™, mobile app, and all associated tests) is subject to review by the FDA and/or other regulatory bodies and is not currently available for sale.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a
View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-to-host-fireside-chat-on-november-5th-with-ceo-dwight-egan-to-discuss-recently-announced-definitive-agreement-in-saudi-arabia-302600199.html
SOURCE Co-Diagnostics
FAQ
When is the Co-Diagnostics (CODX) fireside chat on the Saudi Arabia agreement?
What will Co-Diagnostics (CODX) discuss in the November 5, 2025 fireside chat?
How can investors register for the Co-Diagnostics (CODX) November 5, 2025 event?
Will Co-Diagnostics (CODX) answer shareholder questions during the November 5, 2025 chat?
What is the status of the Co-Dx PCR platform mentioned by Co-Diagnostics (CODX)?
Will the Co-Diagnostics (CODX) November 5, 2025 fireside chat be recorded?
